Autoantibody activity in Waldenström's macroglobulinemia

Clinical Lymphoma

Volumn 5, Issue 4, 2005, Pages 225-229

  Stone, Marvin J ^a   Merlini, Giampaolo ^b   Pascual, Virginia ^c  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PAVIA   (Italy)

^c BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

B cells; Cold agglutinins; Cryoglobulinemia; Monoclonal gammopathy; Neuropathy

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; AUTOANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; CARBOHYDRATE ANTIGEN; CD27 ANTIGEN; COLD AGGLUTININ; ERYTHROCYTE ANTIGEN; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; IMMUNOGLOBULIN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; M PROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN; PROTEIN ANTIBODY; RITUXIMAB; SULFATIDE; AGGLUTININ; COLD AGGLUTININS; CRYOGLOBULIN;

ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; B LYMPHOCYTE; CHEMOTHERAPY; COLD EXPOSURE; CROSS REACTION; CRYOGLOBULINEMIA; CYTOTOXICITY; DEMYELINATING NEUROPATHY; DISEASE ASSOCIATION; GENE MUTATION; GENE SEQUENCE; HEMAGGLUTINATION; HEMOLYTIC ANEMIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOTHERAPY; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; MEMORY CELL; MONOCLONAL IMMUNOGLOBULINEMIA; MYCOPLASMA PNEUMONIAE; NONHODGKIN LYMPHOMA; PATHOGENESIS; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; REMISSION; REVIEW; SENSORIMOTOR NEUROPATHY; SENSORY NEUROPATHY; SOMATIC HYPERMUTATION; WALDENSTROEM MACROGLOBULINEMIA; IMMUNOLOGY; NEUROLOGIC DISEASE; PATHOLOGY;

AGGLUTININS; AUTOANTIBODIES; B-LYMPHOCYTES; CRYOGLOBULINS; HUMANS; IMMUNOGLOBULIN M; NERVOUS SYSTEM DISEASES; WALDENSTROM MACROGLOBULINEMIA;

EID: 18144416948     PISSN: 15269655     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2005.n.004     Document Type: Review

References (45)

1. Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 2003; 30:110-115.
2. Sahota SS, Forconi F, Ottensmeier CH, et al. Origins of the malignant clone in typical Waldenstrom's macroglobulinemia. Semin Oncol 2003; 30:136-141.
3. Stone MJ. Monoclonal antibodies in the prehybridoma era: a brief historical perspective and personal reminiscence. Clin Lymphoma 2001; 2:148-154.
4. Stone MJ, McElroy YG, Pestronk A, et al. Human monoclonal macroglobulins with antibody activity. Semin Oncol 2003; 30:318-324.
5. Lebecque S, de Bouteiller O, Arpin C, et al. Germinal center founder cells display propensity for apoptosis before onset of somatic mutation. J Exp Med 1997; 185:563-571.
6. Meffre E, Davis E, Schiff C, et al. Circulating human B cells that express surrogate light chains and edited receptors. Nat Immunol 2000; 1:207-213.
7. Wardemann H, Yurasov S, Schaefer A, et al. Predominant autoantibody production by early human B cell precursors. Science 2003; 301:1374-1377.
8. Arce E, Jackson DG, Gill MA, et al. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol 2001; 167:2361-2369.
9. Weller S, Faili A, Garcia C, et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. PNAS 2001; 98:1166-1170.
10. Weller S, Braun MC, Tan BK, et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004; 104:3647-3654.
11. Christenson W, Dacie J. Serum proteins in acquired hemolytic anemia (auto-antibody type). Br J Haematol 1957; 3:153-164.
12. Waldenström J, Winblad S, Hallen J, et al. The occurrence of serological "antibody" reagins or similar gamma-globulins in conditions with monoclonal hypergammaglobulinemia, such as myeloma, macrglobulinemia, etc. Acta Med Scand 1964; 176:619-631.
13. H4-21 gene segment is required to encode anti-I and anti-i specificities. J Immunol 1992; 149:2337-2344.
14. Potter KN, Hobby P, Klijn S, et al. Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34 encoded Igs in recognition of the red blood cell I antigen. J Immunol 2002; 169:3777-3782.
15. Kritzman J, Kunkel H, McCarthy J, et al. Studies of a Waldenström-type macroglobulin with rheumatoid factor properties. J Lab Clin Med 1961; 57:905-917.
16. Stone M, Metzger H. The valence of a Waldenström macroglobulin antibody and further thoughts on the significance of paraprotein antibodies. Cold Spring Harbor Symp Quant Biol 1967; 32:83-88.
17. Stone MJ, Metzger H. Binding properties of a Waldenström macroglobulin antibody. J Biol Chem 1968; 243:5977-5984.
18. Stone MJ, Metzger H. The specificity of a monoclonal macroglobulin (gamma M) antibody: reactivity with primate gamma G immunoglobulins. J Immunol 1969; 102:222-228.
19. Stone MJ. Studies on monoclonal antibodies. I. The specificity and binding properties of a Waldenström macroglobulin with anti-γ G activity. J Lab Clin Med 1973; 81:393-409.
20. Stone MJ, Fedak JE. Studies on monoclonal antibodies. II. Immune complex (IgM-IgG) cryoglobulinemia: the mechanism of cryoprecipitation. J Immunol 1974; 113:1377-1385.
21. Corper AL, Sohi MK, Bongura VR, et al. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nature Structural Biol 1997; 4:374-381.
22. Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitic C viral infection. Springer Semin Immunopathol 1997; 19:111-129.
23. Dammacco F, Sansonno D, Piccoli C, et al. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy. Semin Liver Dis 2000; 20:143-157.
24. Agnello V, DeRosa FG. Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol 2004; 40:341-352.
25. Sansonno D, Lauletta G, Nisi L, et al. Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinemia. Clin Exp Immunol 2003; 133:275-282.
26. Monteverde A, Ballare M, Pileri S. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Immunopathol 1997; 19:99-110.
27. DeRe V, DeVita S, Marzotto A, et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000; 96:3578-3584.
28. Musto P. Hepatitis C virus infection and B-cell non-Hodgkin's lymphomas: more than a simple association. Clin Lymphoma 2002; 3:150-160.
29. Casato M, Mecucci C, Agnello V, et al. Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia. Blood 2002; 99:2259-2261.
30. Patriarca F, Silvestri F, Fanin R, et al. Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment. Br J Haematol 2001; 112:370-372.
31. Zaja F, DeVita S, Mazzaro C, et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 2003; 101:3827-3834.
32. Hermine O, Lefrere F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347:89-94.
33. Fehr T, Bachmann MF, Bucher E, et al. Role of repetitive antigen patterns for induction of antibodies against antibodies. J Exp Med 1997; 185:1785-1792.
34. L kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998; 91:2433-2442.
35. Dellagi K, Brouer J, Danon F. Cross-idiotypic antigens among monoclonal immunoglobulin M from patients with Waldenström's macroglobulinemia and polyneuropathy. J Clin Invest 1979; 64:1530-1534.
36. Latov N, Sherman WH, Nemni R, et al. Plasma-cell dyscrasia and peripheral neuropathy with monoclonal antibody to peripheral-nerve myelin. N Engl J Med 1980; 303:618-621.
37. Ropper AH, Gorson KC. Neuropathies associated with paraproteinemia. N Engl J Med 1998; 338:1601-1607.
38. Vital A. Paraproteinemic neuropathies. Brain Pathol 2001; 11:399-407.
39. Pestronk A, Choksi R, Logigian E, et al. Sensory neuropathy with monoclonal IgM binding to a trisulfated heparin disaccharide. Muscle Nerve 2003; 27:188-195.
40. Prendergast MM, Willison HJ, Moran AP. Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndrome. Infect Immun 1999; 67:3698-3701.
41. Merlini G, Farhangi M, Osserman EF. Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias. Semin Oncol 1986; 13:360-365.
42. Potter M. Myeloma proteins and antibodies. In: Moulin AM, Cambrosio A, eds. Singular Selves. Historical Issues and Contemporary Debates in Immunology. Paris, France: Elsevier; 2001:23-43.
43. Kriangkum J, Taylor BJ, Treon SP, et al. Clonotypic IgM V/D/J sequence analysis in Waldenström macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood. Blood 2004; 104:2134-2142.
44. Marrack P, Kappler J, Korzin BL. Autoimmune disease: why and where it occurs. Nat Med 2001; 7:899-905.
45. Ferrarini M, Chiorazzi N. Recent advances in the molecular biology and immunobiology of chronic lymphocytic leukemia. Semin Hematol 2004; 41:207-223.